Cardiovascular age (CV age) is a concise way to sum up the overall
health risk of your heart and blood vessels. Determining a person’s
cv age is essential to choose the right preventative interventions for
reducing the risk of heart related diseases
"A man is as old as his arteries"
CardioInspect enabling a personalized and predective analysis of cardiovascular health
You might have a much higher cardiovascular age than you are aware
An MRI – based analysis from cardioinspect is the best way to accurately measure your cardiovascular risk level.
Cardiovascular age is reversible. You could lose 5+ years of cardiovascular age thanks to tailored and easy to implement prevention program. As used at the London Bart’s Heart Center and highlighted on BBC News
Fast Cine – SSFP
MRI acquisition protocole
Transfert of anonymised DICOM Data to cardioinspect for analysis
Clinical report generated and sent to physician & patient
Transfer to our expert team your anonymized MRI Data through our secured platform for image analysis and biomarkers calculation.
Using a our CE certified technology we calculates the Ascending Aortic Distensibility, which is the core of our biomarker and its a measure of the stiffness of the central arteries. This is done by precisely tracking how the aorta moves and combining this information with the pressure in your blood vessels.
We then benchmark these results against what is considered normal for a healthy population, allowing Cadiolnspect to provide the most precise and relevant cardiovascular age for prevention.
You will geta personal report that screen the cardiovascular age and detect the earliest signs of CV disease based on our propriatery data. And, if necessary, clinical support to implement a personalized therapy to improve and reduce CV age & risk as well as to measure the impact on the anti-aging therapy
CardioInspect is based on our technology Artfun+ the Europe’s first MDR CE class 2a medical device for predictive cardiovascular medicine, and the world’s most clinically validated to analyse arterial function by MRI. Our imaging biomarkers are the earliest manifestation of vascular aging, and the strongest predictor of cardiovascular risk for intermediate risk patients. Validated in a world-famous clinical trial (MESA study) led by Johns Hopkins , sponsored by the NIH, with 3’675 patients followed-up over 8.5 years
Talk with our cardiologist & radiologist experts for a free proposal cardiovascular check-up
Imageens, a prominent French MedTech startup, had the privilege of participating in Medica 2021, where we unveiled our state-of-the-art…
Imageens is excited to announce its strategic partnership with Mieux. This collaboration aims to elevate cardiovascular health assessment through…
Imageens, a pioneering startup in medical imaging technology, proudly announces its collaboration with the renowned Pitié Salpêtrière Hospital, aimed…
After extensive research and clinical validation, Imageens is proud to introduce CardioInspect. This marks a significant step towards providing patients…
Paris, France – August 4, 2021 Imageens showcased its presence at the prestigious ‘Journées Francophones de Radiologie’ (JFR) 2021 by…
